1 min read
AbbVie Q3 Preview Centers on $3.77 Earnings Per Share Estimate
AbbVie is scheduled to report before U.S. markets open Friday, Oct. 30. Wall Street analysts expect Skyrizi and Rinvoq to drive the quarter.

AbbVie heads into Friday’s third-quarter report with a $3.77 earnings-per-share forecast, more than twice last year’s level, as Wall Street analysts expect Skyrizi and Rinvoq to boost results.
The estimate is for the quarter, not a reported result. AbbVie is scheduled to release its results before U.S. markets open Friday, Oct. 30.